The Co-Stars study prospectively enrolled 3679 healthcare workers to comprehensively characterize the kinetics of SARS-CoV-2 spike (S), receptor-binding-domain (RBD) and nucleoprotein (N) antibodies in parallel. Participants screening seropositive had serial monthly serological testing for a maximum of 7 months with the Mesoscale Discovery Assay
[Clinical Infectious Diseases]
6445218
{6445218:BIAJ8NRY}
apa
50
1
164222
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/